Ticker LaunchReverse merger · Completed · DNTH
Dianthus Therapeutics, Inc. (OpCo)
Reverse merger with Magenta Therapeutics, Inc. (MGTA)
Dianthus Therapeutics, Inc. (OpCo) merged into Magenta Therapeutics, Inc. (MGTA), a Nasdaq-listed biotech that adopted a rights plan while pursuing a strategic transaction, in a reverse merger that takes the private company public. The agreement was signed and the deal closed on the same day, Sep 11, 2023. The combined company trades as Dianthus Therapeutics, Inc. (DNTH) on Nasdaq.
- Status
- Completed
- Private company
- Dianthus Therapeutics, Inc. (OpCo)
- Public company
- Magenta Therapeutics, Inc. (MGTA)
- Public company business before
- Nasdaq-listed biotech that adopted a rights plan while pursuing a strategic transaction
- Announced
- Signed and closed the same day
- Closed
- Sep 11, 2023
- Combined company
- Dianthus Therapeutics, Inc. (DNTH)
- Exchange
- Nasdaq
- Sector
- Biotech & pharma
More on this deal for subscribers
- Reverse stock split
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Closing 8-K Sep 12, 2023
- Closing press release
- All filings on EDGAR CIK 1690585
Other completed reverse mergers
- Tourmaline Bio, Inc.into Talaris Therapeutics, Inc. · Oct 19, 2023
- Notable Labs, Inc.into Vascular Biogenics Ltd. · Oct 16, 2023
- Hong Chang Global Investment Holdings Limited (Hongchang BVI)into Heyu Biological Technology Corporation · Sep 7, 2023
- EIP Pharma, Inc.into Diffusion Pharmaceuticals Inc. · Aug 16, 2023
- Dror Ortho-Design Ltd. (Israel)into Novint Technologies, Inc. · Aug 14, 2023
- Serve Robotics Inc.into Patricia Acquisition Corp. · Jul 31, 2023